Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CTSV | O60911 | 2/20 | 0.54 |
| ▸ | CTSL | P07711 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8034446 | 0.98 | ALDH1A1 (0.61) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL6554357 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL31415352 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL33664 | 0.85 | ALDH1A1 (0.64) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL2371651 | 0.85 | ALDH1A1 (0.64) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL31557908 | 0.85 | ALDH1A1 (0.56) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL510143 | 0.84 | ALDH1A1 (0.58) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL4437870 | 0.84 | KMT2A (0.60) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL3133108 | 0.84 | ALDH1A1 (0.62) | ALDH1A1MAPTTDP1TSHRCYP3A4 | |
| SCHEMBL13844164 | 0.84 | KMT2A (0.60) | ALDH1A1MAPTTDP1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409619-A | Isoindolone derivative and preparation method thereof | 辽宁石油化工大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119080334-A | Comprehensive utilization method of nitric acid containing organic matters | 山东友道化学有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-9932473-B2 | Encapsulating resin composition, semiconductor device using the encapsulating resin composition, and method for manufacturing semiconductor device using the encapsulating resin composition | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2018-04-03 | — | — | US | claimed |
| EP-0927714-B1 | PROCESS FOR THE SEPARATION OF NITROTOLUIC ACID ISOMERS | SUMIKIN CHEMICAL (JP) | 2002-04-10 | — | — | EP | claimed |
| US-6054609-A | ADDING AN AROMATIC ORGANIC BASE TO MIXTURE OF 3-NITRO-O-TOLUIC ACID AND 5-NITRO-O-TOLUIC ACID AND EFFICIENTLY RECOVERING BOTH 3-NITRO-O-TOLUIC ACID AND 5-NITRO-O-TOLUIC ACID BY TAKING ADVANTAGE OF DIFFERENCE BETWEEN IN THEIR SOLUBILITY TO WATER | SUMIKIN CHEMICAL CO., LTD. (JP) | 2000-04-25 | — | — | US | claimed |
| EP-0927714-A1 | PROCESS FOR THE SEPARATION OF NITROTOLUIC ACID ISOMERS | SUMIKIN CHEMICAL CO., LTD. (JP) | 1999-07-07 | — | — | EP | claimed |
| EP-0902683-A1 | AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES | RADOPATH LIMITED (GB) | 1999-03-24 | — | — | EP | claimed |
| WO-1997034593-A1 | AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES | RADOPATH LIMITED (GB) | 1997-09-25 | — | — | WO | claimed |
| JP-10324667-A | — | — | None | — | — | JP | disclosed |
| WO-2026098644-A1 | TARGETED PROTEIN DEGRADATION AGENT, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 北京森妙生物科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| CN-121270371-A | Preparation method of 3-chloro-5-fluoro-2-methylbenzoic acid | 潍坊市海欣药业有限公司 | 2026-01-06 | — | — | CN | disclosed |
| US-20250289826-A1 | PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF | TSINGHUA UNIVERSITY (CN) | 2025-09-18 | — | — | US | disclosed |
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| US-4192947-A | REACTING DIAMINO NITROBENZENE WITH NITROBENZOYL CHLORIDE, CYCLIZING ANILIDE IN AQUEOUS ALKALI, REDUCING NITRO GROUPS WITH SULFIDE | CASSELLA AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | disclosed |
| EP-0001246-A1 | Preparation of 2-(3'- or 4'-aminophenyl)-5(or 6)-aminobenzimidazoles | CASSELLA Aktiengesellschaft (DE) | 1979-04-04 | — | — | EP | disclosed |
| US-4127602-A | Methyl substituted hydroxynaphthalenesulfonic acid ureides and salts as complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1978-11-28 | — | — | US | disclosed |
| US-4103028-A | SUBSTITUTED HYDROXY NAPHTHALENEDISULFONIC ACIDS | AMERICAN CYANAMID COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-4046805-A | Substituted-hydroxy-naphthalenedisulfonic acid compounds | AMERICAN CYANAMID COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-4036838-A | Process for the production of nitro derivatives of aromatic compounds | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391663-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | ALDH1A1 1142/4885MAPT 4795/4885TDP1 4627/4885 |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CLIC1 | ALDH1A1 592/4885MAPT 4672/4885TDP1 2103/4885 |
| US-20250289826-A1 | PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF | ACE, PLP2, ACE2 | ALDH1A1 3835/4885MAPT 676/4885TDP1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.